VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CLVT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CLVTClarivate Plc
$2.19$1.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCLVTBalance Sheet

Clarivate Plc (CLVT) Balance Sheet

9Y historyFree accessUpdated daily

The company's financial position appears strained with a current ratio of 0.84 and a significant $4.3 billion total debt burden relative to its $4.8 billion equity base.

CLVT Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17
Total Current Assets1.3B1.31B1.24B1.46B1.4B1.64B1.15B493.08M408.61M443.91M
Cash & Short-Term Investments232.3M329.2M295.2M370.7M348.8M587.61M257.73M76.13M25.57M53.19M
Cash Only232.3M329.2M295.2M370.7M348.8M587.61M257.73M76.13M25.57M53.19M
Short-Term Investments0000000000
Accounts Receivable882.9M821.7M798.3M908.3M872.1M906.43M737.73M333.86M331.3M317.81M
Days Sales Outstanding124.39122.16113.97126.11119.68176.27214.71125.07124.86126.41
Inventory000097.4M00031.03M52.76M
Days Inventory Outstanding----37.27---28.5648.85
Other Current Assets76.8M159.1M65.2M94.7M76.9M66.65M93.83M42.38M31.13M44.52M
Total Non-Current Assets9.63B9.76B10.25B11.24B12.55B18.55B13.64B3.3B3.3B3.56B
Property, Plant & Equipment93.4M99.3M107.1M106.8M113.4M169.88M168.62M103.49M20.64M23.01M
Fixed Asset Turnover24.18x24.73x23.87x24.61x23.46x11.05x7.44x9.41x46.92x39.88x
Goodwill1.57B1.57B1.57B2.02B2.88B7.9B6.04B1.33B1.28B1.31B
Intangible Assets7.86B8.01B8.44B9.01B9.44B10.39B7.37B1.83B1.96B2.16B
Long-Term Investments13M014.7M17.7M47.2M1.96M0000
Other Non-Current Assets85.8M68.1M67.5M43.1M50.7M48.75M31.33M18.63M26.56M60.03M
Total Assets10.93B11.07B11.49B12.71B13.94B20.18B14.79B3.79B3.71B4.01B
Asset Turnover0.22x0.22x0.22x0.21x0.19x0.09x0.08x0.26x0.26x0.23x
Asset Growth %-20.69%-3.66%-9.57%-8.88%-30.91%36.46%290.11%2.2%-7.38%-
Total Current Liabilities1.54B1.57B1.43B1.6B1.56B1.9B1.42B651M643.71M661.07M
Accounts Payable135.7M150.6M124.5M144.1M101.4M129.22M82.04M26.46M38.42M60.76M
Days Payables Outstanding61.4965.9452.2858.0338.875.3368.2427.4435.3756.26
Short-Term Debt1.5M119.9M20.6M24.4M26.7M62.75M28.6M9M60.34M45.34M
Deferred Revenue (Current)3.68B878.6M943.9M983.1M947.5M1.03B707.32M407.32M391.1M361.26M
Other Current Liabilities100.6M419.7M-20.6M321.9M326.4M348.01M57.75M26.87M00
Current Ratio0.84x0.84x0.87x0.91x0.89x0.86x0.81x0.76x0.63x0.67x
Quick Ratio0.84x0.84x0.87x0.91x0.83x0.86x0.81x0.76x0.59x0.59x
Cash Conversion Cycle62.9---118.15---118.06119
Total Non-Current Liabilities4.6B4.66B4.92B5.11B5.57B6.36B4.33B1.89B2.02B2.06B
Long-Term Debt4.28B4.36B4.52B4.72B4.97B5.46B3.46B1.63B1.93B1.97B
Capital Lease Obligations125.6M053.2M63.2M72.9M93.95M104.32M64.19M00
Deferred Tax Liabilities975.9M212.1M273.3M249.6M316.1M380.06M367M48.55M43.23M51.79M
Other Non-Current Liabilities75.9M86.2M55.9M41.9M171.4M370.59M362.2M130.7M24.84M22.61M
Total Liabilities6.14B6.23B6.35B6.71B7.13B8.26B5.76B2.54B2.66B2.72B
Total Debt4.33B4.48B4.59B4.81B5.1B5.61B3.63B1.72B1.99B2.01B
Net Debt4.1B4.15B4.3B4.44B4.76B5.03B3.37B1.65B1.96B1.96B
Debt / Equity0.91x0.92x0.89x0.80x0.75x0.47x0.40x1.38x1.89x1.57x
Debt / EBITDA4.93x5.41x10.17x--12.45x13.59x14.60x15.14x24.72x
Net Debt / EBITDA4.67x5.01x9.52x--11.15x12.62x13.96x14.94x24.07x
Interest Coverage0.47x0.27x-0.95x-2.45x-13.76x-0.02x-2.16x-0.58x-0.81x-1.06x
Total Equity4.79B4.84B5.14B5.99B6.81B11.93B9.03B1.25B1.05B1.29B
Equity Growth %-32.45%-5.76%-14.24%-12.04%-42.88%32%623.59%18.85%-18.31%-
Book Value per Share7.477.197.418.9210.0418.6121.084.563.444.21
Total Shareholders' Equity4.79B4.84B5.14B5.99B6.81B11.93B9.03B1.25B1.05B1.29B
Common Stock12.8B12.81B12.98B11.74B11.74B11.83B9.99B2.14B16K16K
Retained Earnings-7.55B-7.51B-7.31B-6.65B-5.66B-1.6B-1.25B-890.89M-632.26M-390.1M
Treasury Stock00000-16.96M-196.04M000
Accumulated OCI-457.7M-453.1M-526.3M-495.3M-665.9M326.75M492.38M-4.88M5.36M13.98M
Minority Interest0000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

High leverage and goodwill

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Asset Base Contraction Amidst Stagnation

As reported in recent financial statements, Clarivate's total assets have declined from $12.7 billion in 2023Q4 to $10.9 billion in 2026Q1, signaling a potential reduction in the company's scale as it navigates a period of persistent revenue contraction and ongoing integration challenges.

The steady erosion of the asset base suggests that the company may be struggling to replace the value of its acquired intangibles through organic growth. Investors should monitor whether this downward trajectory in total assets reflects a strategic divestiture of non-core assets or an impairment-driven reduction in the carrying value of its portfolio.

Leverage Remains Elevated Despite Deleveraging

Based on the provided balance sheet data, Clarivate's total debt has decreased from $4.8 billion in 2023Q4 to $4.3 billion in 2026Q1, yet the debt-to-equity ratio remains elevated at 0.91, indicating that the company continues to carry a significant interest-bearing burden relative to its equity base.

While the modest reduction in absolute debt levels is a positive development, the persistent reliance on debt financing in a high-interest-rate environment may continue to pressure net margins. The company's leverage appears to be a legacy of its aggressive M&A strategy, which now limits its financial flexibility to pursue new growth initiatives.

Erosion of Shareholder Equity Base

According to the company's reported figures, shareholder equity has contracted from $6.0 billion in 2023Q4 to $4.8 billion in 2026Q1, a trend largely driven by the accumulation of negative retained earnings which reached -$7.6 billion in the most recent quarter.

The consistent growth in negative retained earnings suggests that the company's operational losses are directly eroding the capital base. This trend warrants further investigation into whether the company's capital allocation strategy, including share repurchases, is sustainable given the ongoing depletion of equity.

Tight Liquidity Buffers Constrain Flexibility

As indicated by the latest quarterly filings, Clarivate's current ratio has remained consistently below 1.0, standing at 0.84 in 2026Q1, which suggests that the company may face challenges in meeting its short-term obligations without relying on external financing or cash flow from operations.

A current ratio below unity is often a sign of structural liquidity constraints, particularly for a firm with high fixed costs and significant debt service requirements. Investors should monitor the company's cash runway closely, as the current liquidity position provides a limited buffer against potential operational shocks or unexpected capital needs.

Goodwill Impairment Risk Remains Significant

Based on the provided balance sheet, Clarivate carries $1.6 billion in goodwill as of 2026Q1, which represents a substantial portion of the company's total equity and suggests that future earnings could be volatile if management is forced to recognize impairments on past acquisitions.

The presence of significant goodwill on the balance sheet implies that the company's valuation is highly sensitive to the performance of its acquired business units. If the expected synergies from these acquisitions fail to materialize, the resulting impairment charges could further weaken the balance sheet and exacerbate the current negative net margin trend.

CLVT — Frequently Asked Questions

Quick answers to the most common questions about buying CLVT stock.

What are the total assets of Clarivate Plc (CLVT)?

As of 2025, Clarivate Plc (CLVT) had total assets of $11.07B including $1.31B in current assets.

How much debt does Clarivate Plc (CLVT) have?

Clarivate Plc (CLVT) carries total debt of $4.48B, offset by $329.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Clarivate Plc?

Clarivate Plc (CLVT) has total shareholders' equity (book value) of $4.84B ($7.19 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Clarivate Plc's current ratio and liquidity?

Clarivate Plc (CLVT) reported a current ratio of 0.84x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.